RNAZ

TransCode Therapeutics Inc

May 19 • 11:52AM ET

6.42

+0.25 4.05 %

Healthcare • Biotechnology • USA • Nano • NASD

Peers: IMNN BCDA SHPH HOTH ARTL

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-48.65	Insider Own	9.08%	Shs Outstand	0.92M	Perf Week	-4.61%
Market Cap	6.10M	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	0.83M	Perf Month	-27.74%
Enterprise Value	136.53M	PEG	-	EPS next Q	-	Inst Own	7.90%	Short Float	4.31%	Perf Quarter	-30.22%
Income	-43.70M	P/S	-	EPS this Y	-	Inst Trans	3.98%	Short Ratio	3.76	Perf Half Y	-30.52%
Sales	0.00M	P/B	4.70	EPS next Y	-	ROA	-47.38%	Short Interest	0.04M	Perf YTD	-6.00%
Book/sh	1.36	P/C	0.47	EPS next 5Y	-	ROE	-52.14%	52W High	20.99 -69.41%	Perf Year	-4.18%
Cash/sh	13.52	P/FCF	-	EPS past 3/5Y	96.25% 79.17%	ROIC	-27.93%	52W Low	6.02 6.64%	Perf 3Y	-100.00%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	10.89% 7.58%	Perf 5Y	-
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	95.40%	Oper. Margin	-	ATR (14)	0.61	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	3.11	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	29.14	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	3.11	EPS Q/Q	69.67%	SMA20	-15.59%	Beta	1.38	Target Price	280.00
Payout	-	Debt/Eq	0.00	Sales Q/Q	-	SMA50	-23.75%	Rel Volume	1.76	Prev Close	6.17
Employees	12	LT Debt/Eq	0.00	Earnings	-	SMA200	-33.85%	Avg Volume	9.50K	Price	6.42
IPO	Jul 09, 2021	Option/Short	No / Yes	EPS/Sales Surpr.	67.35% -100.00%	Trades		Volume	6,657	Change	4.05%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)